Joel D Greenberg

发表

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

Gregg W Stone, G. Stone, S. Ellis, 2005, JAMA.

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

G. Stone, S. Ellis, C. O'shaughnessy, 2004, The New England journal of medicine.

Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.

Charles L. Brown, P. Fitzgerald, G. Stone, 2010, Cardiovascular revascularization medicine : including molecular interventions.

Pivotal, randomized U.S. study of the Symbiot™ covered stent system in patients with saphenous vein graft disease: Eight‐month angiographic and clinical results from the Symbiot III trial

N. Weissman, M. Buchbinder, J. Popma, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

elationship Between Angiographic ate Loss and Target Lesion evascularization After Coronary Stent Implantation

C. O'shaughnessy, J. Popma, J. Lasala, 2005 .

Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts

M. Leon, D. Baim, J. Popma, 2002, Circulation.

Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.

G. Stone, N. Weissman, S. Ellis, 2005, Journal of the American College of Cardiology.

Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).

G. Stone, N. Weissman, S. Ellis, 2008, The American journal of cardiology.

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

Gregg W Stone, G. Stone, S. Ellis, 2004, Circulation.

Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial.

G. Stone, S. Ellis, C. O'shaughnessy, 2005, Journal of the American College of Cardiology.

Cerebral infarction in sickle cell trait

Joel D Greenberg, E. Massey, 1985, Annals of neurology.

Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials.

G. Stone, N. Weissman, G. Mintz, 2008, JACC. Cardiovascular interventions.

Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials.

G. Stone, N. Weissman, S. Ellis, 2007, European heart journal.

Internal mammary artery perfusing Leriche's syndrome in association with significant coronary arteriosclerosis: Four case reports and review of literature

Joel D Greenberg, J. R. Arnold, Karan Reddy, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial

G. Stone, S. Ellis, C. O'shaughnessy, 2004, Circulation.

Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).

K. Dawkins, E. Grube, Joel D Greenberg, 2008, The American journal of cardiology.